DISA Uranium has agreed to acquire a portfolio of uranium projects in Colorado from Premier American Uranium, expanding its footprint in the western US uranium sector. The deal includes a $5 million strategic equity investment in Premier American Uranium, giving DISA a board seat and aligning the companies for future collaboration. This acquisition complements DISA's existing assets in Utah and supports its strategy to consolidate domestic uranium resources using its proprietary remediation technology. The transaction aims to enhance the US uranium supply chain by increasing feedstock sources and developing new recovery and processing capacity.
DISA Uranium's recent strategic transaction with Premier American Uranium provides context for the Basic Materials sector. For readers following this sector, here is Pluang's market snapshot as of Sep 15, 2026 16:51 WIB: out of 32 priced US Basic Materials stocks tradable on Pluang, 10 rose and 20 fell. Notable movers include NEM (Newmont Corporation) at USD 121.83 with a -1.01% change, KGC (Kinross Gold Corporation) at USD 27.90 with a -0.99% change, and ALB (Albemarle Corp.) at USD 114.00 with a -0.90% change.
NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy with an aggressive brain tumor treated with investigational intranasal NEO100 under compassionate use in Abu Dhabi. The child is now breathing independently...
TransUnion's Branded Call Display, a solution that helps consumers identify legitimate callers and avoid robocall fraud, has been named one of TIME's Best Inventions of 2026 in the Connectivity & Communication category. The technology displays a busi...
La Rosa Holdings Corp. will change its name to Stratum Holdings Corp. on October 19, 2026, reflecting its shift from real estate services to an AI infrastructure company specializing in GPU leasing and high-performance computing. The company recently...
ASUS has released the ProArt P16 and P14 laptops in Canada, powered by NVIDIA RTX Spark technology. These laptops feature up to 128GB of unified memory and advanced AI capabilities designed for creators, AI developers, and workflow builders, enabling...
OXB, a global cell and gene therapy CDMO, has appointed Dr Joachim Kreuzburg as an Independent Non-Executive Director effective November 23, 2026. Dr Kreuzburg brings over 20 years of leadership in life sciences, notably transforming Sartorius AG int...
